Duke Accepts Potti Resignation; Retraction Process Initiated with Nature Medicine

Anil Potti, MD, has voluntarily resigned from his positions as associate professor of medicine at Duke University School of Medicine and at the university's Institute for Genome Sciences & Policy. Dr. Potti's resignation is effective immediately.

In addition, Dr. Potti's collaborator, Joseph Nevins, PhD, has initiated a process intended to lead to a retraction request regarding a paper previously published in Nature Medicine.

This process has been initiated due to concerns about the reproducibility of reported predictors, and their possible effect on the overall conclusions in this paper. Other papers published based on this science are currently being reviewed for any concerns.

The three clinical trials based on this science, for which new enrollment was suspended in mid-July, have been closed.

Suggested Articles

Data from a 10,000-patient trial showed that people with osteoarthritis taking Novartis' Ilaris had 40% to 47% lower rates of joint replacements.

Immunic's lead asset beat placebo at reducing damage to myelin, which protects nerve fibers, in patients with relapsing multiple sclerosis.

The appointment sees Kobayashi switch from developing Dermira’s anti-IL-13 drug to advancing Aslan’s would-be rival.